Vivo Capital Revenue and Competitors
Estimated Revenue & Valuation
- Vivo Capital's estimated annual revenue is currently $20M per year.
- Vivo Capital's estimated revenue per employee is $227,000
- Vivo Capital's total funding is $5.8B.
Employee Data
- Vivo Capital has 88 Employees.
- Vivo Capital grew their employee count by 5% last year.
Vivo Capital's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Controller | Reveal Email/Phone |
2 | Managing Director | Reveal Email/Phone |
3 | Chief Operating Officer | Reveal Email/Phone |
4 | Legal Director | Reveal Email/Phone |
5 | Executive Director | Reveal Email/Phone |
6 | Chief Investment Officer - Opportunity Fund | Reveal Email/Phone |
7 | Managing Director | Reveal Email/Phone |
8 | Managing Director | Reveal Email/Phone |
9 | Managing Director | Reveal Email/Phone |
10 | Senior Director Human Resources | Reveal Email/Phone |
Vivo Capital Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $3.8M | 24 | 0% | N/A | N/A |
#2 | $4.3M | 27 | -4% | N/A | N/A |
#3 | $1.9M | 14 | -22% | N/A | N/A |
#4 | $13.7M | 67 | 8% | N/A | N/A |
#5 | $27M | 119 | 28% | N/A | N/A |
#6 | $12.1M | 59 | 34% | N/A | N/A |
#7 | $21.1M | 93 | 3% | N/A | N/A |
#8 | $23.4M | 103 | -8% | N/A | N/A |
#9 | $4.3M | 27 | 0% | N/A | N/A |
#10 | $7.6M | 45 | N/A | N/A | N/A |
What Is Vivo Capital?
Vivo Capital is a healthcare focused investment firm formed in 1996 with over $1.7 billion under management. Vivo Capital is currently making investments from its $750M eighth fund into promising private and public healthcare companies in the U.S. and greater China. Vivo employs a unique multi-pronged strategy of identifying and working with companies with promising development stage and commercial stage therapeutic products in the U.S. and revenue stage companies in China. Vivo Capital has offices in Palo Alto, California, Shanghai, China, and Chengdu, China. With over 100 years of scientific expertise and operating experience in healthcare, Vivo makes investment decisions for the Funds and helps its portfolio companies develop corporate strategy, facilitate strategic alliances including cross-border partnerships, recruit management, and acquire new products and technologies to accelerate growth. Vivo's current portfolio includes more than 80 private and public biotechnology companies in the areas of biopharmaceuticals, specialty pharmaceuticals, and medical devices.
keywords:N/A
$5.8B
Total Funding
88
Number of Employees
$20M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Vivo Capital News
Founded in 1996, Vivo Capital is a leading global healthcare investment firm with a diverse, multi-fund investment platform in venture capital,...
VIVO ISAR is the first Dual Drug Polymer-Free Coronary Stent technology, ... Everstone Capital invested in Translumina in 2019 to further...
In Vivo's 2022 Rising Leaders are listed in alphabetical order. Thijs Cohen Tervaert. INKEF Capital. Manuela Corti. University of Florida.
Other Companies in Palo Alto
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $12.8M | 88 | 4% | N/A |
#2 | $12.8M | 88 | 5% | $190M |
#3 | $17.8M | 88 | -4% | N/A |
#4 | $3.5M | 89 | -5% | N/A |
#5 | $13.1M | 90 | 3% | N/A |